Cigna Group $CI Holdings Lowered by Clarius Group LLC

Clarius Group LLC reduced its holdings in Cigna Group (NYSE:CI) by 3.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,719 shares of the health services provider’s stock after selling 140 shares during the quarter. Clarius Group LLC’s holdings in Cigna Group were worth $1,229,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Flaharty Asset Management LLC bought a new stake in shares of Cigna Group in the 1st quarter worth approximately $28,000. 1248 Management LLC bought a new stake in shares of Cigna Group in the 1st quarter worth approximately $29,000. Activest Wealth Management raised its holdings in shares of Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares in the last quarter. Retirement Wealth Solutions LLC raised its holdings in shares of Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock worth $33,000 after purchasing an additional 43 shares in the last quarter. Finally, Saudi Central Bank bought a new stake in shares of Cigna Group in the 1st quarter worth approximately $36,000. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Performance

Shares of CI opened at $311.24 on Friday. The company’s 50 day moving average price is $292.41 and its 200 day moving average price is $309.73. Cigna Group has a 52 week low of $256.89 and a 52 week high of $358.88. The company has a market capitalization of $83.08 billion, a PE ratio of 16.99, a PEG ratio of 0.91 and a beta of 0.45. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the previous year, the firm posted $6.72 earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 1.9%. Cigna Group’s payout ratio is presently 32.97%.

Wall Street Analyst Weigh In

A number of research firms recently commented on CI. Cantor Fitzgerald reiterated an “overweight” rating and issued a $365.00 target price on shares of Cigna Group in a report on Tuesday, August 26th. Wells Fargo & Company cut their price target on shares of Cigna Group from $341.00 to $340.00 and set an “equal weight” rating on the stock in a report on Thursday, August 14th. Guggenheim restated a “buy” rating and set a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. Finally, Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a report on Friday. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $371.81.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.70% of the company’s stock.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.